Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice

Malarvannan Pannirselvam, Valerie Simon, Subodh Verma, Todd Anderson, Christopher Triggle

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

1. We previously reported that acute incubation with tetrahydrobiopterin (BH 4) or sepiapterin, a cofactor for endothelial nitric oxide synthase and a stable precursor of BH 4, respectively, enhanced the acetylcholine (Ach)-induced relaxation of isolated small mesenteric arteries (SMA) from diabetic (db/ db) mice. In this study, we investigated the effect of chronic oral supplementation of sepiapterin (10 mg kg -1 day -1) to db/db mice on endothelium function, biopterin levels and lipid peroxidation in SMA. 2. Oral dietary supplementation with sepiapterin had no effect on glucose, triglyceride, cholesterol levels and body weight. SMA from db/db mice showed enhanced vascular reactivity to phenylephrine, which was corrected with sepiapterin supplementation. Furthermore, Ach, but not sodium nitroprusside-induced relaxation, was improved with sepiapterin supplementation in db/db mice. 3. BH 4 levels and guanosine triphosphate cyclohydrolase I activity in SMA were similar in db/+ and db/db mice. Sepiapterin treatment had no effects on BH 4 or guanosine triphosphate cyclohydrolase I activity. However, the level of dihydrobiopterin + biopterin was higher in SMA from db/db mice, which was corrected following sepiapterin treatment. 4. Thiobarbituric acid reactive substance, malondialdehyde, a marker of lipid peroxidation, was higher in SMA from db/db mice, and was normalized by sepiapterin treatment. 5. These results indicate that sepiapterin improves endothelial dysfunction in SMA from db/db mice by reducing oxidative stress. Furthermore, these results suggest that decreased biosynthesis of BH 4 may not be the basis for endothelial dysfunction in SMA from db/db mice.

Original languageEnglish
Pages (from-to)701-706
Number of pages6
JournalBritish Journal of Pharmacology
Volume140
Issue number4
DOIs
Publication statusPublished - Oct 2003
Externally publishedYes

Fingerprint

Mesenteric Arteries
Oxidative Stress
Biopterin
Guanosine Triphosphate
Lipid Peroxidation
Acetylcholine
sepiapterin
Thiobarbituric Acid Reactive Substances
Nitric Oxide Synthase Type III
Nitroprusside
Phenylephrine
Dietary Supplements
Malondialdehyde
Endothelium
Blood Vessels
Triglycerides
Cholesterol
Body Weight
Glucose

Keywords

  • db/db mice
  • Endothelial dysfunction
  • Oxidative stress
  • Sepiapterin
  • Tetrahydrobiopterin
  • Type II diabetes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. / Pannirselvam, Malarvannan; Simon, Valerie; Verma, Subodh; Anderson, Todd; Triggle, Christopher.

In: British Journal of Pharmacology, Vol. 140, No. 4, 10.2003, p. 701-706.

Research output: Contribution to journalArticle

@article{a3bc7b7cf5c74581be6e476b5fa48cb0,
title = "Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice",
abstract = "1. We previously reported that acute incubation with tetrahydrobiopterin (BH 4) or sepiapterin, a cofactor for endothelial nitric oxide synthase and a stable precursor of BH 4, respectively, enhanced the acetylcholine (Ach)-induced relaxation of isolated small mesenteric arteries (SMA) from diabetic (db/ db) mice. In this study, we investigated the effect of chronic oral supplementation of sepiapterin (10 mg kg -1 day -1) to db/db mice on endothelium function, biopterin levels and lipid peroxidation in SMA. 2. Oral dietary supplementation with sepiapterin had no effect on glucose, triglyceride, cholesterol levels and body weight. SMA from db/db mice showed enhanced vascular reactivity to phenylephrine, which was corrected with sepiapterin supplementation. Furthermore, Ach, but not sodium nitroprusside-induced relaxation, was improved with sepiapterin supplementation in db/db mice. 3. BH 4 levels and guanosine triphosphate cyclohydrolase I activity in SMA were similar in db/+ and db/db mice. Sepiapterin treatment had no effects on BH 4 or guanosine triphosphate cyclohydrolase I activity. However, the level of dihydrobiopterin + biopterin was higher in SMA from db/db mice, which was corrected following sepiapterin treatment. 4. Thiobarbituric acid reactive substance, malondialdehyde, a marker of lipid peroxidation, was higher in SMA from db/db mice, and was normalized by sepiapterin treatment. 5. These results indicate that sepiapterin improves endothelial dysfunction in SMA from db/db mice by reducing oxidative stress. Furthermore, these results suggest that decreased biosynthesis of BH 4 may not be the basis for endothelial dysfunction in SMA from db/db mice.",
keywords = "db/db mice, Endothelial dysfunction, Oxidative stress, Sepiapterin, Tetrahydrobiopterin, Type II diabetes",
author = "Malarvannan Pannirselvam and Valerie Simon and Subodh Verma and Todd Anderson and Christopher Triggle",
year = "2003",
month = "10",
doi = "10.1038/sj.bjp.0705476",
language = "English",
volume = "140",
pages = "701--706",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice

AU - Pannirselvam, Malarvannan

AU - Simon, Valerie

AU - Verma, Subodh

AU - Anderson, Todd

AU - Triggle, Christopher

PY - 2003/10

Y1 - 2003/10

N2 - 1. We previously reported that acute incubation with tetrahydrobiopterin (BH 4) or sepiapterin, a cofactor for endothelial nitric oxide synthase and a stable precursor of BH 4, respectively, enhanced the acetylcholine (Ach)-induced relaxation of isolated small mesenteric arteries (SMA) from diabetic (db/ db) mice. In this study, we investigated the effect of chronic oral supplementation of sepiapterin (10 mg kg -1 day -1) to db/db mice on endothelium function, biopterin levels and lipid peroxidation in SMA. 2. Oral dietary supplementation with sepiapterin had no effect on glucose, triglyceride, cholesterol levels and body weight. SMA from db/db mice showed enhanced vascular reactivity to phenylephrine, which was corrected with sepiapterin supplementation. Furthermore, Ach, but not sodium nitroprusside-induced relaxation, was improved with sepiapterin supplementation in db/db mice. 3. BH 4 levels and guanosine triphosphate cyclohydrolase I activity in SMA were similar in db/+ and db/db mice. Sepiapterin treatment had no effects on BH 4 or guanosine triphosphate cyclohydrolase I activity. However, the level of dihydrobiopterin + biopterin was higher in SMA from db/db mice, which was corrected following sepiapterin treatment. 4. Thiobarbituric acid reactive substance, malondialdehyde, a marker of lipid peroxidation, was higher in SMA from db/db mice, and was normalized by sepiapterin treatment. 5. These results indicate that sepiapterin improves endothelial dysfunction in SMA from db/db mice by reducing oxidative stress. Furthermore, these results suggest that decreased biosynthesis of BH 4 may not be the basis for endothelial dysfunction in SMA from db/db mice.

AB - 1. We previously reported that acute incubation with tetrahydrobiopterin (BH 4) or sepiapterin, a cofactor for endothelial nitric oxide synthase and a stable precursor of BH 4, respectively, enhanced the acetylcholine (Ach)-induced relaxation of isolated small mesenteric arteries (SMA) from diabetic (db/ db) mice. In this study, we investigated the effect of chronic oral supplementation of sepiapterin (10 mg kg -1 day -1) to db/db mice on endothelium function, biopterin levels and lipid peroxidation in SMA. 2. Oral dietary supplementation with sepiapterin had no effect on glucose, triglyceride, cholesterol levels and body weight. SMA from db/db mice showed enhanced vascular reactivity to phenylephrine, which was corrected with sepiapterin supplementation. Furthermore, Ach, but not sodium nitroprusside-induced relaxation, was improved with sepiapterin supplementation in db/db mice. 3. BH 4 levels and guanosine triphosphate cyclohydrolase I activity in SMA were similar in db/+ and db/db mice. Sepiapterin treatment had no effects on BH 4 or guanosine triphosphate cyclohydrolase I activity. However, the level of dihydrobiopterin + biopterin was higher in SMA from db/db mice, which was corrected following sepiapterin treatment. 4. Thiobarbituric acid reactive substance, malondialdehyde, a marker of lipid peroxidation, was higher in SMA from db/db mice, and was normalized by sepiapterin treatment. 5. These results indicate that sepiapterin improves endothelial dysfunction in SMA from db/db mice by reducing oxidative stress. Furthermore, these results suggest that decreased biosynthesis of BH 4 may not be the basis for endothelial dysfunction in SMA from db/db mice.

KW - db/db mice

KW - Endothelial dysfunction

KW - Oxidative stress

KW - Sepiapterin

KW - Tetrahydrobiopterin

KW - Type II diabetes

UR - http://www.scopus.com/inward/record.url?scp=0242409173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242409173&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0705476

DO - 10.1038/sj.bjp.0705476

M3 - Article

VL - 140

SP - 701

EP - 706

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -